Author

M. Delibegovic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:metabolism & bioenergetics· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Sil· 1 shared B. Platt· 1 shared D. Thompson· 1 shared M. K. Doherty· 1 shared M. Souza Matos· 1 shared N. Mody· 1 shared N. Morrice· 1 shared P. D. Whitfield· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. Sil

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

How stra(i)nge are your controls? A comparative analysis of metabolic phenotypes in commonly used C57 substrains

A. Sil, M. Souza Matos, M. Delibegovic, B. Platt

This study compares metabolic phenotypes across five C57BL/6 substrains from two vendors, revealing vendor- and sex-dependent differences in glucose regulation and insulin signaling.

bioRxiv · Mar 3, 2023 · PreprintPhysiology

Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice.

D. Thompson, S. Mahmood, N. Morrice, S. Kamli-Salino, R. Dekeryte, P. Hoffmann, M. K. Doherty, P. D. Whitfield, M. Delibegovic, N. Mody

This study shows that fenretinide reduces obesity and fatty liver but increases ceramides via Smpd3, worsening atherosclerosis in LDLR-/- mice.

bioRxiv · Jul 22, 2022Physiology